List of Tables
Table 1. Global Peptide Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peptide Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peptide Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peptide Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Peptide Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peptide Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peptide Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peptide Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peptide Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peptide Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptide Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Peptide Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peptide Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global Peptide Therapy Sales Market Share by Region (2020-2025)
Table 19. Global Peptide Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global Peptide Therapy Sales Market Share by Region (2026-2031)
Table 21. Global Peptide Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peptide Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global Peptide Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peptide Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America Peptide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peptide Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America Peptide Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America Peptide Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peptide Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peptide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peptide Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe Peptide Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe Peptide Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peptide Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peptide Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peptide Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Peptide Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Peptide Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peptide Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peptide Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Peptide Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Peptide Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peptide Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peptide Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peptide Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Peptide Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Peptide Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peptide Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peptide Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global Peptide Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global Peptide Therapy Sales Market Share by Type (2020-2025)
Table 53. Global Peptide Therapy Sales Market Share by Type (2026-2031)
Table 54. Global Peptide Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peptide Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peptide Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global Peptide Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global Peptide Therapy Price (US$/Unit) by Type (2020-2025)
Table 59. Global Peptide Therapy Price (US$/Unit) by Type (2026-2031)
Table 60. Global Peptide Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global Peptide Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global Peptide Therapy Sales Market Share by Application (2020-2025)
Table 63. Global Peptide Therapy Sales Market Share by Application (2026-2031)
Table 64. Global Peptide Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peptide Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peptide Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global Peptide Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global Peptide Therapy Price (US$/Unit) by Application (2020-2025)
Table 69. Global Peptide Therapy Price (US$/Unit) by Application (2026-2031)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Eli Lilly Peptide Therapy Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AstraZeneca Peptide Therapy Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Merck Peptide Therapy Product
Table 84. Merck Recent Developments/Updates
Table 85. Ipsen Company Information
Table 86. Ipsen Description and Business Overview
Table 87. Ipsen Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Ipsen Peptide Therapy Product
Table 89. Ipsen Recent Developments/Updates
Table 90. Novo Nordisk Company Information
Table 91. Novo Nordisk Description and Business Overview
Table 92. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Novo Nordisk Peptide Therapy Product
Table 94. Novo Nordisk Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Company Information
Table 96. Teva Pharmaceutical Industries Description and Business Overview
Table 97. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceutical Industries Peptide Therapy Product
Table 99. Teva Pharmaceutical Industries Recent Developments/Updates
Table 100. Abbott Laboratories Company Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Laboratories Peptide Therapy Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Peptide Therapy Product
Table 109. Sanofi Recent Developments/Updates
Table 110. J & J Company Information
Table 111. J & J Description and Business Overview
Table 112. J & J Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. J & J Peptide Therapy Product
Table 114. J & J Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Novartis Peptide Therapy Product
Table 119. Novartis Recent Developments/Updates
Table 120. Takeda Company Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Takeda Peptide Therapy Product
Table 124. Takeda Recent Developments/Updates
Table 125. Ferring Company Information
Table 126. Ferring Description and Business Overview
Table 127. Ferring Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Ferring Peptide Therapy Product
Table 129. Ferring Recent Developments/Updates
Table 130. AbbVie Company Information
Table 131. AbbVie Description and Business Overview
Table 132. AbbVie Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. AbbVie Peptide Therapy Product
Table 134. AbbVie Recent Developments/Updates
Table 135. Heinis Company Information
Table 136. Heinis Description and Business Overview
Table 137. Heinis Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Heinis Peptide Therapy Product
Table 139. Heinis Recent Developments/Updates
Table 140. Hemmo Company Information
Table 141. Hemmo Description and Business Overview
Table 142. Hemmo Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Hemmo Peptide Therapy Product
Table 144. Hemmo Recent Developments/Updates
Table 145. Emcure Pharmaceutical Company Information
Table 146. Emcure Pharmaceutical Description and Business Overview
Table 147. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Emcure Pharmaceutical Peptide Therapy Product
Table 149. Emcure Pharmaceutical Recent Developments/Updates
Table 150. Cipla Company Information
Table 151. Cipla Description and Business Overview
Table 152. Cipla Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Cipla Peptide Therapy Product
Table 154. Cipla Recent Developments/Updates
Table 155. Gland Pharma Company Information
Table 156. Gland Pharma Description and Business Overview
Table 157. Gland Pharma Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Gland Pharma Peptide Therapy Product
Table 159. Gland Pharma Recent Developments/Updates
Table 160. Troikaa Pharmaceuticals Company Information
Table 161. Troikaa Pharmaceuticals Description and Business Overview
Table 162. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Troikaa Pharmaceuticals Peptide Therapy Product
Table 164. Troikaa Pharmaceuticals Recent Developments/Updates
Table 165. Biological E Company Information
Table 166. Biological E Description and Business Overview
Table 167. Biological E Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Biological E Peptide Therapy Product
Table 169. Biological E Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Peptide Therapy Distributors List
Table 173. Peptide Therapy Customers List
Table 174. Peptide Therapy Market Trends
Table 175. Peptide Therapy Market Drivers
Table 176. Peptide Therapy Market Challenges
Table 177. Peptide Therapy Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peptide Therapy
Figure 2. Global Peptide Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide Therapy Market Share by Type: 2024 & 2031
Figure 4. Parenteral Route of Administration Product Picture
Figure 5. Mucosal Route of Administration Product Picture
Figure 6. Oral Route of Administration Product Picture
Figure 7. Transdermal Route of Administration Product Picture
Figure 8. Global Peptide Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Peptide Therapy Market Share by Application: 2024 & 2031
Figure 10. Cancer
Figure 11. Cardiovascular Diseases
Figure 12. Gastrointestinal Disorders
Figure 13. Metabolic Disorders
Figure 14. Others
Figure 15. Global Peptide Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Peptide Therapy Market Size (2020-2031) & (US$ Million)
Figure 17. Global Peptide Therapy Sales (2020-2031) & (K Units)
Figure 18. Global Peptide Therapy Average Price (US$/Unit) & (2020-2031)
Figure 19. Peptide Therapy Report Years Considered
Figure 20. Peptide Therapy Sales Share by Manufacturers in 2024
Figure 21. Global Peptide Therapy Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Peptide Therapy Players: Market Share by Revenue in Peptide Therapy in 2024
Figure 23. Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Peptide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Peptide Therapy Sales Market Share by Country (2020-2031)
Figure 26. North America Peptide Therapy Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Peptide Therapy Sales Market Share by Country (2020-2031)
Figure 30. Europe Peptide Therapy Revenue Market Share by Country (2020-2031)
Figure 31. Germany Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Peptide Therapy Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Peptide Therapy Revenue Market Share by Region (2020-2031)
Figure 38. China Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Peptide Therapy Sales Market Share by Country (2020-2031)
Figure 49. Latin America Peptide Therapy Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Peptide Therapy Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Peptide Therapy Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. U.A.E Peptide Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Peptide Therapy by Type (2020-2031)
Figure 59. Global Revenue Market Share of Peptide Therapy by Type (2020-2031)
Figure 60. Global Peptide Therapy Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Peptide Therapy by Application (2020-2031)
Figure 62. Global Revenue Market Share of Peptide Therapy by Application (2020-2031)
Figure 63. Global Peptide Therapy Price (US$/Unit) by Application (2020-2031)
Figure 64. Peptide Therapy Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
